This report provides understanding of the Indian diabetes market and its key segments including Oral Antidiabetics, Insulin and Diabetes Diagnostics. It provides current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. Read Full Report on Indian Diabetes Market: http://www.imarcgroup.com/india-diabetes

1. Indian Diabetes Market
Report: Patients, Prevalence,
Oral Antidiabetics, Insulin and
Diagnostics
Imarc
www.imarcgroup.com
Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
Consulting Services

2. The International Market Analysis Research and Consulting Group is a leading advisor on management
strategy and market research worldwide. We partner with clients in all sectors and regions to identify
their highest-value opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food
and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.
About IMARC GroupImarc
www.imarcgroup.com

3. Report Description and HighlightsImarc
www.imarcgroup.com
New Report Provides a Comprehensive Insight into the Indian Insulin, Oral Antidiabetics and
Diabetes Diagnostics Market
Driven by a rising patient pool and continuously increasing healthcare expenditures, the market for diabetes
drugs and diagnostics is expanding robustly in India. This is creating lucrative opportunities for global
healthcare companies at a time when growth rates in the more developed markets have declined.
Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently
being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to
over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are
genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes
is expected to be one of the biggest epidemics the country has ever witnessed.
India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and
diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the
healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country.
This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the
more developed markets have declined.
IMARC’s new report “Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and
Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report
provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment
of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral
Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report

4. Report Description and HighlightsImarc
www.imarcgroup.com
provides historical and future market sales, performance of key classes and the performance of top players.
The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic
structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an
excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to
foray into the Indian diabetes market in some form or the other.
What we have achieved in this report:
Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:
Focus of the Analysis:
• Historical, current and future prevalence of diabetes in India
• Historical, current and future prevalence of type-1 and type-2 diabetes in India
• Historical, current and future prevalence of diabetes in the urban and rural regions in India
• Historical, current and future prevalence of diabetes among males and females in India
• Historical, current and future prevalence of diabetes among various age groups in India
• Historical, current and future diagnosis rates for diabetes in India
• Historical, current and future drug treatment rates for diabetes in India
Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
• Performance of the Oral Antidiabetics market in India
• Performance of key classes
• Performance of key players
• Market outlook

5. Indian Diabetes MarketImarc
www.imarcgroup.com

6. Report Description and HighlightsImarc
www.imarcgroup.com
Comprehensive situation analysis of the Indian Insulin market and its dynamics:
Focus of the Analysis:
• Performance of the Insulin market in India
• Performance of key classes
• Performance of key players
• Market outlook
Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:
Focus of the Analysis:
• Performance of the diabetes diagnostics market in India
• Performance of key classes
• Performance of key players
• Market outlook
Table of Contents
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications

7. Report Description and HighlightsImarc
www.imarcgroup.com
4 Factors Driving the Diabetes Market in India
4.1 Increasing Obesity Levels
4.2 Urbanization
4.3 India has the Second Largest Diabetes Patient Base in the World
4.4 India Represents One of the Fastest Growing Markets Globally
4.5 Improving Diagnosis and Treatment Rates
5 The Indian Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region (Urban and Rural)
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates
6 Indian Diabetes Market
6.1 Historical Market Trends (2007-2014)
6.2 Market Breakup by Segment (2007-2014)
6.3 The Indian Oral Antidiabetics Market
6.3.1 Historical Market Trends (2007-2014)
6.3.2 Market Breakup by Class (2007-2014)
6.3.3 Market Shares of Key Players
6.3.4 Market Outlook (2015-2020)
6.4 The Indian Insulin Market
6.4.1 Historical Market Trends (2015-2020)
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players

8. Report Description and HighlightsImarc
www.imarcgroup.com
6.4.4 Market Outlook (2015-2020)
6.5 Market Outlook (2015-2020)
7 Indian Diabetes Diagnostics Market
7.1.1 Historical Market Trends (2007-2014)
7.1.2 Market Segmentation
7.1.3 Market Shares of Key Players
7.1.4 Market Outlook (2015-2020)
List of Figures
Figure 3 1: The Impact of Diabetes on the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: India: Overweight & Obese Population (in Millions), 2007, 2014 & 2020
Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2014 & 2030
Figure 5 1: India: Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 2: India: Total Number of Diabetes Patients (in Millions), 2015 - 2020
Figure 5 3: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 4: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions) 2015 - 2020
Figure 5 5: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 6: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2015 - 2020
Figure 5 7: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2007- 2014
Figure 5 8: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2015 - 2020
Figure 5 9: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions),
2007- 2014

9. Report Description and HighlightsImarc
www.imarcgroup.com
Figure 5 10: India: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions),
2015 - 2020
Figure 5 11: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2007- 2014
Figure 5 12: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2015 - 2020
Figure 6 1: India: Diabetes Market (in Million US$), 2007-2014
Figure 6 2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2007-2014
Figure 6 3: India: Oral Antidiabetics Market (in Million US$), 2007-2014
Figure 6 4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2007-2014
Figure 6 5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)
Figure 6 6: India: Oral Antidiabetics Market Forecast (in Million US$), 2015-2020
Figure 6 7: India: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020
Figure 6 8: India: Insulin Market (in Million US$), 2005-2012
Figure 6 9: India: Insulin Market: Sales Share of Key Classes (in %), 2012
Figure 6 10: India: Insulin Market: Sales Share of Key Players (in %), 2012
Figure 6 11: India: Insulin Market Forecast (in Million US$), 2015-2020
Figure 6 12: India: Insulin Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020
Figure 6 13: India: Diabetes Market Forecast (in Million US$), 2015-2020
Figure 6 14: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020
Figure 7 1: India: Glucose Monitoring Market (in Million US$), 2007-2014
Figure 7 2: India: Glucose Monitoring Market: Sales Share by Segment (in %),
Figure 7 3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)
Figure 7 4: India: Glucose Monitoring Market Forecast (in Million US$), 2015-2020

10. Report Description and HighlightsImarc
www.imarcgroup.com
List of Tables
Table 2 1: India: Diabetes Epidemiology: Executive Summary
Table 2 2: India: Diabetes Market: Executive Summary
Table 3 1: Diagnosis of Diabetes
Table 4 1: India: Overweight & Obesity Statistics, 2006, 2010 & 2014
Table 4 2: India: Urban & Rural Population Breakup (in Millions), 1991, 2001, 2011 & 2014
Table 4 3: Global: Diabetes Population Breakup by Country (in 000’s), 2014 & 2020
Table 4 4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 5 1: India: Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 4: India (Male & Female): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In
Millions), 2007, 2014 & 2020
Table 5 6: India: Total Diagnosed & Drug Treated Diabetes Population, 2007, 2014 & 2020

11. Report Description and HighlightsImarc
www.imarcgroup.com
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/india-diabetes

12. Report Description and HighlightsImarc
www.imarcgroup.com
© 2015 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

13. FOR MORE DETAILS
Visit us at :
http://www.imarcgroup.com
Stay With Us:
TELEPHONE: +91-120-4155099
E-MAIL: sales@imarcgroup.com
Imarc
www.imarcgroup.com